News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Liquidia Technologies Inc. Appoints Dr. Benjamin Yerxa as Chief Scientific Officer


8/28/2012 9:55:53 AM

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Liquidia Technologies, a privately held biotechnology company developing particle-based vaccines and therapeutics, today announced it has named Benjamin Yerxa, Ph.D. as the company’s Chief Scientific Officer. Dr. Yerxa will be responsible for research and development and the overall scientific direction of the company, including a focus on scientific collaborations.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES